Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Initiating Phase I/II clinical trials on patients at risk or already infected

Date added: 05 May 2020

Projects should leverage clinical trials expertise to rapidly intiate clinical trials for prevention and/or treatment for COVID-19

Amount
Not limited
Agency or Funder
National Heart, Lung, and Blood Institute
Eligibility (if available)

Must already possess an NHLBI Phase I-III clinical trial award

Foreign participation? (where known)
No
Date application deadline